LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (The Common Stock Purchase and Option Agreement) (Details) (USD $)	0 Months Ended														1 Months Ended	3 Months Ended		12 Months Ended
	Dec. 27, 2013		Oct. 14, 2013	Oct. 14, 2013	Aug. 19, 2013		Jul. 29, 2013		Jun. 28, 2013		May 20, 2013		May 21, 2013		Jun. 30, 2013	Sep. 30, 2013	Jun. 30, 2013	Dec. 31, 2014	Dec. 31, 2013
Class of Stock [Line Items]
Issuance of stock, shares	25,961,538	[1],[2]	11,538,462	38,500,000	12,500,000	[1],[2]	11,538,462	[1],[2]	28,125,000	[1],[3]	78,125,000	[1],[3]	15,625,000	[1],[3]	28,125,000	24,000,000	121,900,000
Shares issued, price per share (USD per share)	$ 0.52	[2]	$ 0.52	$ 0.52	$ 0.52	[2]	$ 0.52	[2]	$ 0.32	[3]	$ 0.32	[3]	$ 0.32	[3]
Amount Invested	$ 13,500,000	[2]			$ 6,500,000	[2]	$ 6,000,000	[2]	$ 9,000,000	[3]	$ 25,000,000	[3]	$ 5,000,000	[3]	$ 9,000,000	$ 12,500,000	$ 39,000,000		$ 65,000,000
Issuance of stock	47,250,000	[2]	20,000,000		7,750,000	[2]	7,154,000	[2]	15,469,000	[3]	31,250,000	[3]	6,250,000	[3]				114,211,000
Loss on sale of shares																(2,400,000)
Thermo Capital Partners LLC
Class of Stock [Line Items]
Issuance of stock																			82,726,000
Thermo Capital Partners LLC | Scenario, Plan | Option One
Class of Stock [Line Items]
Shares issued, price per share (USD per share)																		$ 0.52
Issuance of stock																		13,500,000
Thermo Capital Partners LLC | Scenario, Plan | Option Two
Class of Stock [Line Items]
Issuance of stock																		$ 11,500,000
Percentage of average closing price																		85.00%

[1] All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.

[2] Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

[3] Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.